EAM
BSX icon

Empirical Asset Management’s Boston Scientific BSX Stock Holding History

Empirical Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$343K Sell
8,030
-11,453
-59% -$622K 0.08% 291
2026
Q1 		$1.22M Buy
+19,483
New +$1.56M 0.32% 83
2025
Q1 		– Sell
-16,204
Closed -$45.9K – 330
2024
Q4 		$45.9K Buy
+16,204
New +$1.43M 0.02% 383

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Empirical Asset Management's BSX Position: Q2 2026 in Review

Empirical Asset Management reduced its Boston Scientific (BSX) stake by 59% in Q2 2026, selling an estimated $622K and leaving 8,030 shares worth $343K. The position accounts for 0.08% of the portfolio, ranked #291.

Empirical Asset Management first reported a position in BSX in Q4 2024 and has held it in 3 quarters since. The position peaked at $1.22M in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Empirical Asset Management held 8,030 shares of Boston Scientific worth $343K as of Q2 2026.
  • Empirical Asset Management sold 11,453 Boston Scientific shares in Q2 2026, an estimated $622K.
  • Boston Scientific made up 0.08% of Empirical Asset Management's portfolio in Q2 2026, its #291 holding.
  • Empirical Asset Management first reported a position in Boston Scientific in Q4 2024 and has held it in 3 quarters since.
  • Empirical Asset Management's Boston Scientific position peaked at $1.22M in Q1 2026.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Empirical Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.